The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions

Galcanezumab is a humanized monoclonal antibody blocking the calcitonin gene-related peptide (CGRP) pathway by targeting the CGRP. Data from four phase-3 randomized placebo-controlled clinical trials showed that galcanezumab is superior to placebo in reducing migraine headaches, migraine-specific qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gklinos, Panagiotis, Mitsikostas, Dimos D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998387/
https://www.ncbi.nlm.nih.gov/pubmed/33803190
http://dx.doi.org/10.3390/ph14030245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998387/
https://www.ncbi.nlm.nih.gov/pubmed/33803190
http://dx.doi.org/10.3390/ph14030245

Ejemplares similares